Rankl as a prognostic marker in patients with breast cancer
| Varying Title: |
Pharmaceutical studies on modulation of release characteristics and bioavailability of an anti - inflammatory oxicam derivative drug |
|---|---|
| Main Author: | Sara Salama Ashour |
| Date: |
2012
|
| Content Type: | رسائل جامعية |
| Language: | English |
| Granting Institution | Faculty of Pharmacy / Department of Pharmaceutics / Cairo University |
| Country | مصر |
| Source: | غير محدد |
| Status | تمت المناقشة |
| Database(s): | Thesis |
| Description not available. |
Similar Items
-
RANKL and osteoprotegerin gene polymorphisms and their protein levels breast cancer patients
By: Heba Elsayed Elsayed Omar Published: (2012) -
Gingival crevicular fluid level of receptor activator nuclear factor - kappa - B ligand (RANKL) in insulin dependant diabetes mellitus patients
By: Heba Mohamed Tawfik Abdelfattah Published: (2012) -
Range and prevalence of cardiac abnormalities in non cardiac patients hospitalized in A medical ICU
By: Mariam Refaat Helmy Hanna Published: (2012) -
Assessment of serum with resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus
By: Mohammed Farag Ali Assar Published: (2011) -
Non - invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin
By: Ahmed Mohamed Ismail Published: (2010)